This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management

Authoring team

Seek expert advice.

Management of small intestinal bacterial overgrowth (SIBO) generally involves:

  • eradication of bacterial overgrowth with antimicrobial therapy (often requiring repeated courses)
  • correction of associated nutritional deficiencies
  • identification and correction of the underlying predisposing condition, where possible

Antimicrobial therapy:

  • antibiotics used include metronidazole, ciprofloxacin, tetracycline, amoxicillin-clavulanate, neomycin, and rifaximin, with rifaximin being the most extensively investigated (1)
  • hydrogen-predominant bacterial overgrowth:
    • rifaximin 1650 mg/day for 2 weeks is an effective regimen (1)
  • methane-predominant bacterial overgrowth:
    • combining neomycin 1000 mg/day and rifaximin 1650 mg/day for 2 weeks is an effective regimen (2)

Recurrence:

  • approximately 45% of patients experience recurrent SIBO following completion of antibiotic therapy (3)
  • higher recurrence rates are associated with:
    • older age
    • history of appendicectomy
    • chronic use of proton pump inhibitors (3)

Nutritional support:

  • associated vitamin and mineral deficiencies (including vitamin B12, iron, thiamine, niacin, and fat-soluble vitamins) should be identified and corrected accordingly

Reference:

  1. Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013 Oct;38(8):925-34.
  2. Pimentel M, Chang C, Chua KS, Mirocha J, DiBaise J, Rao S, Amichai M. Antibiotic treatment of constipation-predominant irritable bowel syndrome. Dig Dis Sci. 2014 Jun;59(6):1278-85.
  3. Lauritano EC et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol. 2008 Aug;103(8):2031-5.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page